Change in Test Coverage. On March 31, 2023, MolDX -- a Medicare molecular diagnostic testing program administered by Palmetto GBA, a large Medicare administrative contractor -- released an article ...

Early cancer detection often leads to less aggressive treatments, reduced recovery times and higher survival rates.

The test can detect low levels of leukemia cells, known as minimal residual disease (MRD), as the cancer starts to rebound. For the study, researchers recruited 637 patients who were in remission ...

It can be difficult for clinicians to know who may develop the condition, making it harder to prevent or treat. But scientists have now developed a blood test that can predict preeclampsia with 80 ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says.

Mirvie’s blood test uses RNA signatures to resolve this ambiguity, helping pregnant women and their providers focus on the 1 in 4 pregnancies that are truly at high risk, ensuring optimal care ...

A University of St Andrews researcher has received a prestigious £1.6 million Career Development Award from the Medical Research Council (MRC) to develop a blood-based diagnostic tool for ...

Annual blood test could detect cancer in its earliest ... “The advances in molecular biology and artificial intelligence means that we are now able to find tiny fragments of many cancers in a ...

New Molecular Test Could Double Leukemia Survival Rates. May 5, 2025 May 5, 2025 Updated May 5, 2025; 0 ... AML causes bone marrow to produce abnormal white blood cells, ...